Gilead (GILD): Sofosbuvir Doomsday Litigation Scenario Off the Table, Says RBC
Go back to Gilead (GILD): Sofosbuvir Doomsday Litigation Scenario Off the Table, Says RBC| Gilead Sciences (NASDAQ: GILD) | Delayed: 145.68 -3.18 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.86 | 52 Week High | $108.63 | |||
| Open | $149.47 | 52 Week Low | $71.39 | |||
| Day High | $149.47 | P/E | 80.49 | |||
| Day Low | $144.88 | EPS | $1.81 | |||
| Volume | 3,946,913 | |||||
| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 55.19 -1.2 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.39 | 52 Week High | $35.13 | |||
| Open | $55.88 | 52 Week Low | $28.10 | |||
| Day High | $55.89 | P/E | N/A | |||
| Day Low | $55.08 | EPS | $0.00 | |||
| Volume | 1,070,581 | |||||

